faCellitate - a venture of Chemovator GmbH
- Land: Deutschland
Nachricht vom 28.05.2020 | 09:00
faCellitate announces the launch of its first product BIOFLOAT(TM) for improved 3D cell culture
DGAP-News: faCellitate - a venture of Chemovator GmbH
/ Key word(s): Product Launch
faCellitate announces the launch of its first product BIOFLOATTM
- faCellitate releases BIOFLOATTM, its advanced surface coating for 3D cell culture for improved biologically relevant research using spheroid models
- Best-in-class performance enables fast and uniform spheroid formation of a wide range of cell types, including challenging cells
- Pre-coated plates and an easy-to-use self-coating liquid allow flexible experimental designs with maximum convenience
Through biomaterial innovation, faCellitate has developed the new superior cell-inert coating used in BIOFLOATTM for the reliable and reproducible culture of uniform spheroids. 3D spheroids are increasingly becoming the model of choice for drug discovery, toxicology studies, stem cell and cancer research, and other disease models. Here, cell lines or primary cells are cultured in an environment that encourages the formation of 3D spheroids and mimics their natural surroundings, providing a more biologically accurate model system than classic 2D culture on plastic or glass surfaces. Cell characteristics and behavior more closely resemble cell features observed inside their native environment in the organism. However, current tools for 3D culture do not always provide the optimal conditions for cells leading to inconsistent spheroid formation and results, or even failing to produce spheroids for some cell types. BIOFLOATTM overcomes these limitations and provides reliable uniform spheroid formation even for cell types that are challenging to culture in 3D. Thus, results are more reproducible and relevant for human biology, which helps reduce risks when moving from preclinical to clinical research. In addition, use of 3D cell culture can help reduce the number of animal studies required for research and development while saving time and costs.
Dr. Véronique Schwartz, Venture Team Leader and specialist in polymer chemistry, commented: "We are excited that only two years after starting this venture, we can already bring a finished high-quality product to market that outperforms currently available products for 3D cell culture and sets new standards. Using our superior inert surface coating, spheroid culture can deliver reliable results every time. Our BIOFLOATTM product line, including free samples, are now available via the online shop on our website for customers in Europe."
Dr. Barbara Birk, Toxicologist and Laboratory Team leader at BASF SE, added: "BASF SE is very actively developing new alternative toxicological methods with the aim to replace animal studies currently required by regulatory authorities. 3D cell culture techniques, such as spheroids and organoids, are rapidly gaining ground in our research area. Using the BIOFLOATTM in our 3D studies allows us to conveniently generate robust and reproducible spheroids and expands our scope in investigative toxicology."
faCellitate was founded by a group of BASF employees as a part of Chemovator GmbH, the business incubator of BASF, which just celebrated its second birthday. The interdisciplinary team around Dr. Véronique Schwartz strives to improve biological research by providing chemistry-based smart surface coatings for sophisticated cell models. With the launch of BIOFLOATTM, faCellitate is the first life science focused Chemovator venture to bring a product to market, the first in a line of products for the modular functionalization of surfaces for cell culture. Building on their unique knowledge of material chemistry, the team is developing advanced tools to empower biological researcher to take control of their cells' environments and bring cell culture closer to the human body. The unique BIOFLOATTM product line consists of both pre-coated 96-well plates and a ready-to-use self-coating liquid to enable the flexible and rapid coating of most cell culture labware.
About Chemovator GmbH
Further information at www.chemovator.com
If you want to become part of the exclusive Chemovator press distribution list, write an e-mail to firstname.lastname@example.org
For further information, please contact:
Event im Fokus
10. Juni 2021:Fachkonferenz Immobilien
14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure
13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie
10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix
„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“
11 Perlen im „GBC Fonds Champions 2021“
Im Rahmen der aktuellen Studie „GBC Fonds Champions 2021“ haben wir elf versteckte Fondsperlen mit dem Kriterium einer Mindestbewertung von 4 von 5 GBC-Falken ausgewählt. Auch tragen wir dem gesteigerten Investoreninteresse nach nachhaltigen Investments Rechnung und haben drei nachhaltige Fonds ausgewählt. Übrigens, die Fonds aus unserer letzten Ausgabe haben im Schnitt eine Performance von plus 31,8 % erreicht.
Der AKTIONÄR News
19. April 17:39 Tesla: Horror-Crash mit Autopilot – Aktie knickt ein
19. April 16:25 DAX & Co: Schwungvoll am Morgen, kraftlos am Nachmittag
19. April 16:00 Gold ist tot – oder? Newmont im Aufschwung
News im Fokus
Bayerische Motoren Werke Aktiengesellschaft: Wesentliche vorläufige Ergebniskennzahlen der BMW AG für das erste Quartal 2021 über Markterwartungen
19. April 2021, 18:52
Conference Call 11.05.2021 (Webcast)
11. Mai 2021
Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy
19. April 2021